BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu ST, Zhu L, Feng XL, Yang L, Chen GW, Jiang Y, Huang TF, Wang HY, Li F. Advances in neoadjuvant therapy for pancreatic cancer: Current trends and future directions. World J Clin Oncol 2025; 16(6): 105849 [PMID: 40585822 DOI: 10.5306/wjco.v16.i6.105849]
URL: https://www.wjgnet.com/2218-4333/full/v16/i6/105849.htm
Number Citing Articles
1
Maite N.E. Liem, Mats D. Teeken, Mengyuan Ruan, George Molina. Geospatial variation in the treatment of medicare beneficiary pancreatic cancer patients: A SEER-Medicare cohort studyThe American Journal of Surgery 2026; 251: 116684 doi: 10.1016/j.amjsurg.2025.116684
2
Julia Groszewska, Michał Romaniuk, Ewa Małecka-Wojciesko. Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic CancerInternational Journal of Translational Medicine 2025; 5(4): 55 doi: 10.3390/ijtm5040055
3
Dan Brebu, Flaviu Ionut Faur, Mircea Selaru, Cosmin Burta, Carmen Neamtu, Vlad Braicu, Ciprian Duta, Ioana Adelina Faur, Paul Pasca, Amadeus Dobrescu, Razvan Danau. Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: A Systematic Review and Meta-AnalysisLife 2026; 16(4): 561 doi: 10.3390/life16040561
4
Solonas Symeou, Evangelos Lolis, Georgios Glantzounis. Diagnosis and Surgical Management for Advanced Pancreatic Cancer Requiring Vascular ResectionDiagnostics 2025; 16(1): 102 doi: 10.3390/diagnostics16010102